eMIMS Plus

Published by: MIMS PTE
Downloads
Revenue

Description

Including much more information than the first eMIMS of 17 years ago, and with the ability to find it faster than ever, New eMIMS has been developed to meet the needs of our current users.
New eMIMS continues to be the trusted resource you know and love and remains your complete guide to Product Information, Consumer Medicine Information, Product Images, Drug Interactions and PBS restrictions and pricing for all registered medicines in Australia.
Hide Show More...

Screenshots

eMIMS Plus FAQ

  • Is eMIMS Plus free?

    Yes, eMIMS Plus is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is eMIMS Plus legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does eMIMS Plus cost?

    eMIMS Plus is free.

  • What is eMIMS Plus revenue?

    To get estimated revenue of eMIMS Plus app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating

2 out of 5

2 ratings in Australia

5 star
0
4 star
0
3 star
1
2 star
0
1 star
1
Ratings History

eMIMS Plus Reviews

Pill identifier not working.

Percyi on

Australia

Can you please get the pill identifier working again ?

Store Rankings

Ranking History
Category Rankings
Chart
Category
Rank
Top Free
178
Top Free
381

Keywords

eMIMS Plus Competitors

Name
eScription One
APLS Australia
Sonic Dx
iTransfuse
Ausmed - CPD App
For all health professionals.
ARF RHD Guidelines
MBS Search
NSW Ambulance CPG
LocumCo
SAMF

eMIMS Plus Installs

Last 30 days

eMIMS Plus Revenue

Last 30 days

eMIMS Plus Revenue and Downloads

Gain valuable insights into eMIMS Plus performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Publisher
MIMS PTE
Languages
English
Recent release
5.1.18 (8 months ago )
Released on
Dec 1, 2022 (2 years ago )
Last Updated
5 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.